These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 29549971)
1. Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteins. Li Y; Yang T; Yu Y; Shi N; Yang L; Glass Z; Bolinger J; Finkel IJ; Li W; Xu Q Biomaterials; 2018 Sep; 178():652-662. PubMed ID: 29549971 [TBL] [Abstract][Full Text] [Related]
2. Intracellular delivery and biodistribution study of CRISPR/Cas9 ribonucleoprotein loaded bioreducible lipidoid nanoparticles. Li Y; Bolinger J; Yu Y; Glass Z; Shi N; Yang L; Wang M; Xu Q Biomater Sci; 2019 Jan; 7(2):596-606. PubMed ID: 30062347 [TBL] [Abstract][Full Text] [Related]
3. Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. Wang M; Zuris JA; Meng F; Rees H; Sun S; Deng P; Han Y; Gao X; Pouli D; Wu Q; Georgakoudi I; Liu DR; Xu Q Proc Natl Acad Sci U S A; 2016 Mar; 113(11):2868-73. PubMed ID: 26929348 [TBL] [Abstract][Full Text] [Related]
4. Intracellular Delivery of His-Tagged Genome-Editing Proteins Enabled by Nitrilotriacetic Acid-Containing Lipidoid Nanoparticles. Li Y; Li AC; Xu Q Adv Healthc Mater; 2019 Mar; 8(6):e1800996. PubMed ID: 30565897 [TBL] [Abstract][Full Text] [Related]
5. Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles. Liu J; Chang J; Jiang Y; Meng X; Sun T; Mao L; Xu Q; Wang M Adv Mater; 2019 Aug; 31(33):e1902575. PubMed ID: 31215123 [TBL] [Abstract][Full Text] [Related]
6. Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing. Chang J; Chen X; Glass Z; Gao F; Mao L; Wang M; Xu Q Acc Chem Res; 2019 Mar; 52(3):665-675. PubMed ID: 30586281 [TBL] [Abstract][Full Text] [Related]
7. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing. Zhang S; Shen J; Li D; Cheng Y Theranostics; 2021; 11(2):614-648. PubMed ID: 33391496 [TBL] [Abstract][Full Text] [Related]
8. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing. Qiu M; Li Y; Bloomer H; Xu Q Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716 [TBL] [Abstract][Full Text] [Related]
10. RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells. Rouatbi N; Walters AA; Costa PM; Qin Y; Liam-Or R; Grant V; Pollard SM; Wang JT; Al-Jamal KT J Control Release; 2024 Nov; 375():776-787. PubMed ID: 39284526 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of pH-Sensitive Multifunctional Lipids for Efficient Delivery of CRISPR/Cas9 in Gene Editing. Sun D; Sun Z; Jiang H; Vaidya AM; Xin R; Ayat NR; Schilb AL; Qiao PL; Han Z; Naderi A; Lu ZR Bioconjug Chem; 2019 Mar; 30(3):667-678. PubMed ID: 30582790 [TBL] [Abstract][Full Text] [Related]
12. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells. Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703 [TBL] [Abstract][Full Text] [Related]
13. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells. Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759 [TBL] [Abstract][Full Text] [Related]
14. Scaffold-Based Delivery of CRISPR/Cas9 Ribonucleoproteins for Genome Editing. Chooi WH; Chin JS; Chew SY Methods Mol Biol; 2021; 2211():183-191. PubMed ID: 33336278 [TBL] [Abstract][Full Text] [Related]
15. A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing. Finn JD; Smith AR; Patel MC; Shaw L; Youniss MR; van Heteren J; Dirstine T; Ciullo C; Lescarbeau R; Seitzer J; Shah RR; Shah A; Ling D; Growe J; Pink M; Rohde E; Wood KM; Salomon WE; Harrington WF; Dombrowski C; Strapps WR; Chang Y; Morrissey DV Cell Rep; 2018 Feb; 22(9):2227-2235. PubMed ID: 29490262 [TBL] [Abstract][Full Text] [Related]
16. A boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing. Liu C; Wan T; Wang H; Zhang S; Ping Y; Cheng Y Sci Adv; 2019 Jun; 5(6):eaaw8922. PubMed ID: 31206027 [TBL] [Abstract][Full Text] [Related]
17. Delivery of Cas9/sgRNA Ribonucleoprotein Complexes via Hydroxystearyl Oligoamino Amides. Kuhn J; Lin Y; Krhac Levacic A; Al Danaf N; Peng L; Höhn M; Lamb DC; Wagner E; Lächelt U Bioconjug Chem; 2020 Mar; 31(3):729-742. PubMed ID: 31967454 [TBL] [Abstract][Full Text] [Related]
18. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing. Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509 [TBL] [Abstract][Full Text] [Related]
19. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing. Wilbie D; Walther J; Mastrobattista E Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553 [TBL] [Abstract][Full Text] [Related]
20. Intracellular Delivery of mRNA for Cell-Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles. Ma T; Chen X; Wang M Chembiochem; 2023 May; 24(9):e202200801. PubMed ID: 36780174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]